Algernon's financials?What are others thoughts on the Algernon’s financial statements issued a few weeks ago? I keep wonder how these guys stay alive. As of Nov 30 had $2.2M current payables, burning $1.8M per quarter and had $700K in cash. Thus from my calcs they have -$3.3M in payables and basically zero cash today. last quarter they only spent $350K out of $1.8M on R&D, but close to double on marketing and shareholder communications? Are there any near term milestones that could trigger investor interest? Otherwise who’s going to want to fund a company with over $3M in payables and needing millions to fund a clinical trial? They's former CSO Mark Williams left AGN for a new repurposing biotech Marvel bio and they are in same situation with building up large payables that are also beyond cash on hand. What am I missing here, how do they find new investors to cover past expenses and raise $ to actaully run trials?